Arden Trust’s Exact Sciences EXAS Stock Holding History

Arden Trust’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-20	Closed	-$1K	–	469
2020 Q1	$1K	Buy	+20	New	+$1.62K	﹤0.01%	720

Other funds holding EXAS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Arden Trust's EXAS Position: Q2 2020 in Review

Arden Trust sold out of Exact Sciences (EXAS) in Q2 2020, closing a stake of 20 shares — an estimated $1K sold.

Arden Trust first reported a position in EXAS in Q1 2020 and held it in 1 quarter. The position peaked at $1K in Q1 2020. 513 funds tracked by Wall St. Rank hold EXAS as of Q2 2020.

Arden Trust reported no remaining Exact Sciences position as of Q2 2020 after selling out during the quarter.
Arden Trust sold 20 Exact Sciences shares in Q2 2020, an estimated $1K.
Arden Trust first reported a position in Exact Sciences in Q1 2020 and held it in 1 quarter.
Arden Trust's Exact Sciences position peaked at $1K in Q1 2020.
513 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2020.

Based on Arden Trust's 13F filing for Q2 2020, filed 9 Jul 2020.